Helen C C T, Tajunisah I, Reddy S C
Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Int J Ophthalmol. 2011;4(4):443-6. doi: 10.3980/j.issn.2222-3959.2011.04.23. Epub 2011 Aug 18.
To report maternal and fetal adverse outcomes, in spite of appropriate treatment and regular follow up, in diabetic pregnant women with proliferative diabetic retinopathy.
Case series of four young pregnant diabetics aged between 20 and 25 years with type I diabetes mellitus and proliferative diabetic retrinopathy.
The maternal adverse outcomes were abortion in one patient, pre-eclampsia and preterm delivery in one patient, and renal failure requiring dialysis in one patient. The fetal adverse outcomes were neonatal death in one case and premature baby in another case.
These cases highlight the fact that diabetic pregnant women should be closely followed up by the obstetricians and physicians when they have proliferative retinopathy. The proliferative diabetic retinopathy should be considered as a part of the assessment when counseling a diabetic woman in antenatal check up and also in the follow up visits during pregnancy.
报告尽管接受了适当治疗和定期随访,但患有增殖性糖尿病视网膜病变的糖尿病孕妇的母婴不良结局。
对4例年龄在20至25岁之间、患有I型糖尿病和增殖性糖尿病视网膜病变的年轻糖尿病孕妇进行病例系列研究。
孕产妇不良结局包括1例流产、1例先兆子痫和早产、1例需要透析的肾衰竭。胎儿不良结局包括1例新生儿死亡和1例早产。
这些病例凸显了这样一个事实,即患有增殖性视网膜病变的糖尿病孕妇应由产科医生和内科医生密切随访。在对糖尿病妇女进行产前检查咨询以及孕期随访时,应将增殖性糖尿病视网膜病变视为评估的一部分。